BC

BMC Cancer

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Looking to publish in BMC Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 3.4
Quartile Q2
Open Access Type Open
eISSN 1471-2407
Invitation Only No
Cost Range £2690.00 GBP / $3550.00 USD / €3150.00 EUR APC; VAT or local taxes may apply.

Submission Instructions

BMC Cancer accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in BMC Cancer, note any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, confirm the content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusions, and articles reporting health care interventions on human participants must also include a Trial registration section with the registration number and date, adding 'retrospectively registered' when applicable.
Manuscript Manuscript must include a title page identifying all authors and the corresponding author, and the main text must include Methods, Results, Discussion, Conclusions, a Declarations section, and a list of three to ten keywords. Manuscript must include a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, with Authors' information optional, and any non-relevant declaration section must still appear and state 'Not applicable'.
References References must use Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and publicly available preprints may be cited; unpublished abstracts, unpublished data, and personal communications must not appear in the reference list; journal abbreviations must follow Index Medicus/MEDLINE; and web links must be numbered and listed in full with site title, URL, and access date.
Figures & Tables Figure titles and legends must be provided in the main manuscript while figures are uploaded separately, and tables shorter than one page may be placed within the manuscript whereas longer tables may be placed at the end of the text file. Figures must be numbered in text order and multi-panel figures submitted as a single composite file, while tables must be numbered sequentially, created with the word processor's table function rather than embedded as figures or spreadsheets, and manuscripts with cropped gels or blots must provide clearly marked uncropped full-length versions together in one supplementary figure with legends noting their availability.
Reformat to BMC Cancer using Livewrite Premium

Review

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in BMC Cancer, note any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words.
Manuscript Review manuscripts must include Background, Main text, Conclusions, and a Declarations section, and the Main text may be divided into short informative subsections. Review manuscripts must include three to ten keywords and, under Declarations, the sections Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, with 'Not applicable' used for any irrelevant subsection.
References References must follow Vancouver reference style. References must not be cited in the abstract, only published or in-press articles, clinical trial registration records, abstracts, or publicly available preprints may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, web links must be numbered and included in the reference list with full site title, URL, and access date, and publicly available datasets relied on by the paper must be cited with a persistent identifier such as a DOI.
Figures & Tables Tables shorter than one page may be placed in the manuscript text, tables longer than one page may be placed at the end of the document with placement indicated in the text, figure titles and legends must appear in the main manuscript rather than in the graphic file, and figures must be uploaded separately in the order cited. Multi-panel figures must be submitted as a single composite file, tables must not be embedded as figures or spreadsheet files, footnotes must not contain figures or tables, and table footnotes must use superscript lower-case letters or asterisks for significance values and other statistical data.
Reformat to BMC Cancer using Livewrite Premium

Systematic Review

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in BMC Cancer, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusions, and if the review is registered the registration number should appear as the last line of the abstract.
Manuscript Manuscript must include a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, with Not applicable used for any irrelevant section. Manuscript must include three to ten keywords, a list of abbreviations if abbreviations are used, an Availability of data and materials statement, and for systematic reviews a Methods link to an additional file reproducing the full search strategy.
References References must follow Vancouver reference style. Only published or in-press articles, clinical trial registration records, abstracts, and publicly available preprints may be cited, unpublished abstracts/data/personal communications must not appear in the reference list, and web links must be numbered and included as full references with site title, URL, and access date.
Figures & Tables Tables shorter than one page may be placed within the manuscript, longer tables may be placed at the end of the text file, and figures must be uploaded separately in the order first cited. Figure titles and legends must be provided in the manuscript rather than the graphic file, multi-panel figures must be uploaded as a single composite file, and tables must not be embedded as figures.
Reformat to BMC Cancer using Livewrite Premium

Recent Publications

Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centre

Bolanle Adegboyega, Onyinye Balogun, Joy Ogunmuyiwa, Muhammad Habeebu, Okezie Ibeleme, Emmanuel Ojiebun, Oluwatomisin Abraham, Bukola Oshikanlu, Temitope Andero, Pearly Khaw, Anuja Jhingran

10.1186/s12885-026-16311-9
View Publication

Integrating DNA methylation and clinical features to predict prostate cancer prognosis

Yi Qian, Wei Zhu, Zhenxuan Fang, Zeyu Luo, Wenhua Xie, Yifang Cao, Wei Chen, Huiyu Fu, Jiayu Peng, Lijun Zhang, Siyu Lei, Jing Jin, Jieyi Li, Xiaokai Zhao, Ziying Gong, Daoyun Zhang, Yi He

10.1186/s12885-026-16249-y
View Publication

Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progression

Christine Aaserød Pedersen, Maximilian Wess, Maria K. Andersen, Elise Midtbust, Abhibhav Sharma, Thomas Fleischer, Morten Beck Rye, May-Britt Tessem

10.1186/s12885-026-16232-7
View Publication

Evidence for the prognostic value of TP53 mutations in circulating tumor DNA across solid malignancies: a systematic review and meta-analysis

Lan Jinyan, Liang Yibin, Qin Jiangkui, Huang Shanbo, Glenn Deng, Changsheng Sun, He Yongyu, Huang Gang, Yi Tingzhuang

10.1186/s12885-026-16265-y
View Publication

Real-world effectiveness of mecapegfilgrastim for prophylaxis in patients with breast cancer receiving 2-weekly and 3-weekly chemotherapy in China

Yanxia Shi, Peifen Fu, Yongsheng Wang, Yongqing Li, Yumin Yao, Huiping Li, Zhiyong Yu, Lihua Song, Guifang Zhang, Zhangxia Ren, Gang Cheng, Lifang Ding, Jun Yang, Jing Zhang, Jun Bie, Chao Yuan, Zhanggui Wang, Yuihua Xu, Jun Ma

10.1186/s12885-026-16280-z
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 6 days.

Reformat to BMC Cancer using Livewrite Premium

Is a cover letter required?

A cover letter is required and should explain why the manuscript should be published in BMC Cancer, address any issues relating to journal policies, declare potential competing interests, confirm that all authors approved the submission, and confirm that the content has not been published or submitted elsewhere. Special issue submissions should name the specific issue. Authors may also suggest preferred and non-preferred reviewers in the cover letter.

Reformat to BMC Cancer using Livewrite Premium

What are the publication costs?

The article processing charge is £2690.00 GBP / $3550.00 USD / €3150.00 EUR for each accepted article; VAT or local taxes may apply.

Reformat to BMC Cancer using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Breast Cancer Treatment Studies Cancer survivorship and care Global Cancer Incidence and Screening Cancer Cells and Metastasis Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Hepatocellular Carcinoma Treatment and Prognosis Inflammatory Biomarkers in Disease Prognosis Esophageal Cancer Research and Treatment Lung Cancer Diagnosis and Treatment MicroRNA in disease regulation Lung Cancer Research Studies Gastric Cancer Management and Outcomes Cancer, Hypoxia, and Metabolism Colorectal Cancer Treatments and Studies Pancreatic and Hepatic Oncology Research Cancer Risks and Factors Colorectal Cancer Surgical Treatments Endometrial and Cervical Cancer Treatments HER2/EGFR in Cancer Research Cholangiocarcinoma and Gallbladder Cancer Studies Cervical Cancer and HPV Research Glioma Diagnosis and Treatment

Related Journals

MO
Molecular Oncology Elsevier BV
BT
Brain Tumor Pathology Springer Science+Business Media
BE
BMC Endocrine Disorders BioMed Central
BM
Bone Marrow Transplantation Springer Nature
GB
Genome biology BioMed Central
JO
Journal of Clinical Oncology LIPPINCOTT WILLIAMS & WILKINS